The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial.

MLA

Comondore, Vikram R., et al. “The Impact of CPAP on Cardiovascular Biomarkers in Minimally Symptomatic Patients with Obstructive Sleep Apnea: A Pilot Feasibility Randomized Crossover Trial.” Lung, vol. 187, no. 1, Jan. 2009, pp. 17–22. EBSCOhost, https://doi.org/10.1007/s00408-008-9115-5.

APA

Comondore, V. R., Cheema, R., Fox, J., Butt, A., John Mancini, G. B., Fleetham, J. A., Ryan, C. F., Chan, S., & Ayas, N. T. (2009). The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial. Lung, 187(1), 17–22. https://doi.org/10.1007/s00408-008-9115-5

Chicago

Comondore, Vikram R, Rupi Cheema, Joel Fox, Arsalan Butt, G B John Mancini, John A Fleetham, C Frank Ryan, Sammy Chan, and Najib T Ayas. 2009. “The Impact of CPAP on Cardiovascular Biomarkers in Minimally Symptomatic Patients with Obstructive Sleep Apnea: A Pilot Feasibility Randomized Crossover Trial.” Lung 187 (1): 17–22. doi:10.1007/s00408-008-9115-5.